Virtual Market Access Masterclass – Reimbursement in Ireland
€402.44 incl. VAT
Do you struggle to understand the market access landscape in Ireland? Are you spending valuable time trying to navigate the submission pathway? Would some strategic signposting and ‘on the ground’ local knowledge save you time and money?
- Fri, 18 Sep 2020, 09:00 & Wed, 23 Sep 2020, 12:15 BST
- Online Event
Do you struggle to understand the Market Access landscape in Ireland? Are you spending valuable time trying to navigate the submission pathway? Would some strategic signposting and ‘on the ground’ local knowledge save you time and money?
Join AXIS CEO Brenda Dooley and her expert team for their Market Access Masterclass on Reimbursement Applications in Ireland. Normally a one day event, this year’s masterclass will take place online over two half days in September.
The Market Access Virtual Masterclass will provide you with an excellent opportunity to really get behind the scenes of the Irish system, learn how to avoid common submission pitfalls and hear of successful outcomes to reimbursement applications in Ireland.
We have a wonderful line up of guest speakers presenting during the masterclass including Dr Valerie Walshe, Senior Health Economist, Health Service Executive; Philip Watt, CEO Cystic Fibrosis Ireland and Chair of the Irish Rare Disease Taskforce; Fionnuala King, Chief Pharmacist, Acute Hospitals Drug Management Programme and Patricia Heckmann, Chief Pharmacist and National Network Lead – Systemic Therapy Programme, National Cancer Control Programme (NCCP).
This interactive event is strictly for representatives of pharmaceuticals, MedTech, biotech and life science organisations and patient groups. After attending this event, you will come away with a signposted map to reimbursement applications in Ireland, including all the important details and key insights you need to successfully navigate the pathway to reimbursement for your product.
Mr Philip Watt
Philip Watt is CEO of Cystic Fibrosis Ireland. He is also Chairperson of the Rare Disease Taskforce and the Irish Donor Network and a former Chairperson of Health Research Charities Ireland (HRCI) and a founder member of the Irish Health Research Forum.
Dr. Valerie Walshe
Senior Health Economist, Health Service Executive (HSE). Valerie received her PhD from TCD in 2008, under the guidance of Prof. Michael Barry, examining the cost-effectiveness of various drugs reimbursed in Ireland and maintains her interest in this area by working with the Medicines Management Programme and advising on drug reimbursement within the HSE.
Fionnuala King is the Chief Pharmacist for the Acute Hospitals Drug Management Programme. Fionnuala qualified as pharmacist at Robert gordon University, completed post-graduate studies in Clinical Pharmacy at the University of London, a Masters in Leadership and Organisational Learning in the Royal College of Surgeons Dublin.
Chief Pharmacist & National Network Lead – Systemic Therapy Programme, National Cancer Control Programme (NCCP). Patricia Heckmann qualified as a pharmacist at the University of Dublin, Trinity College, before completing a Masters in Health Informatics.